持田製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2013/02/13 | 1,138 | 1,153 | 1,112 | 1,126 | -9 | -0.8% | 90,000 |
2013/02/12 | 1,127 | 1,155 | 1,127 | 1,135 | +13 | +1.2% | 109,000 |
2013/02/08 | 1,139 | 1,139 | 1,122 | 1,122 | -17 | -1.5% | 114,000 |
2013/02/07 | 1,149 | 1,149 | 1,130 | 1,139 | -23 | -2% | 127,000 |
2013/02/06 | 1,168 | 1,177 | 1,159 | 1,162 | -2 | -0.2% | 92,000 |
2013/02/05 | 1,142 | 1,179 | 1,142 | 1,164 | +21 | +1.8% | 153,000 |
2013/02/04 | 1,166 | 1,172 | 1,138 | 1,143 | -22 | -1.9% | 99,000 |
2013/02/01 | 1,183 | 1,183 | 1,160 | 1,165 | -6 | -0.5% | 72,000 |
2013/01/31 | 1,170 | 1,179 | 1,151 | 1,171 | -9 | -0.8% | 137,000 |
2013/01/30 | 1,166 | 1,182 | 1,162 | 1,180 | +14 | +1.2% | 70,000 |
2013/01/29 | 1,182 | 1,186 | 1,159 | 1,166 | -8 | -0.7% | 143,000 |
2013/01/28 | 1,194 | 1,201 | 1,171 | 1,174 | -20 | -1.7% | 127,000 |
2013/01/25 | 1,170 | 1,197 | 1,162 | 1,194 | +21 | +1.8% | 189,000 |
2013/01/24 | 1,124 | 1,175 | 1,121 | 1,173 | +48 | +4.3% | 255,000 |
2013/01/23 | 1,125 | 1,134 | 1,110 | 1,125 | -1 | -0.1% | 150,000 |
2013/01/22 | 1,131 | 1,140 | 1,114 | 1,126 | -5 | -0.4% | 95,000 |
2013/01/21 | 1,126 | 1,135 | 1,117 | 1,131 | +2 | +0.2% | 69,000 |
2013/01/18 | 1,133 | 1,144 | 1,128 | 1,129 | +7 | +0.6% | 86,000 |
2013/01/17 | 1,130 | 1,136 | 1,105 | 1,122 | -11 | -1% | 117,000 |
2013/01/16 | 1,143 | 1,143 | 1,121 | 1,133 | +5 | +0.4% | 143,000 |
2013/01/15 | 1,140 | 1,144 | 1,124 | 1,128 | -6 | -0.5% | 184,000 |
2013/01/11 | 1,113 | 1,137 | 1,109 | 1,134 | +28 | +2.5% | 233,000 |
2013/01/10 | 1,109 | 1,125 | 1,105 | 1,106 | -6 | -0.5% | 167,000 |
2013/01/09 | 1,088 | 1,119 | 1,088 | 1,112 | -1 | -0.1% | 133,000 |
2013/01/08 | 1,105 | 1,122 | 1,096 | 1,113 | +1 | +0.1% | 116,000 |
2013/01/07 | 1,130 | 1,140 | 1,106 | 1,112 | +8 | +0.7% | 180,000 |
2013/01/04 | 1,070 | 1,107 | 1,070 | 1,104 | +45 | +4.2% | 220,000 |
2012/12/28 | 1,071 | 1,071 | 1,053 | 1,059 | -9 | -0.8% | 166,000 |
2012/12/27 | 1,082 | 1,083 | 1,068 | 1,068 | -14 | -1.3% | 94,000 |
2012/12/26 | 1,077 | 1,086 | 1,067 | 1,082 | +16 | +1.5% | 128,000 |
2012/12/25 | 1,073 | 1,082 | 1,066 | 1,066 | -5 | -0.5% | 74,000 |
2012/12/21 | 1,083 | 1,090 | 1,069 | 1,071 | -2 | -0.2% | 164,000 |
2012/12/20 | 1,066 | 1,084 | 1,066 | 1,073 | +15 | +1.4% | 278,000 |
2012/12/19 | 1,066 | 1,068 | 1,053 | 1,058 | -8 | -0.8% | 160,000 |
2012/12/18 | 1,058 | 1,074 | 1,056 | 1,066 | +12 | +1.1% | 138,000 |
2012/12/17 | 1,046 | 1,069 | 1,036 | 1,054 | -2 | -0.2% | 233,000 |
2012/12/14 | 1,069 | 1,074 | 1,056 | 1,056 | -12 | -1.1% | 182,000 |
2012/12/13 | 1,091 | 1,091 | 1,049 | 1,068 | -2 | -0.2% | 149,000 |
2012/12/12 | 1,096 | 1,096 | 1,070 | 1,070 | -19 | -1.7% | 112,000 |
2012/12/11 | 1,099 | 1,099 | 1,089 | 1,089 | -10 | -0.9% | 49,000 |
2012/12/10 | 1,103 | 1,103 | 1,086 | 1,099 | -4 | -0.4% | 67,000 |
2012/12/07 | 1,111 | 1,113 | 1,099 | 1,103 | +3 | +0.3% | 92,000 |
2012/12/06 | 1,096 | 1,110 | 1,096 | 1,100 | +15 | +1.4% | 157,000 |
2012/12/05 | 1,105 | 1,105 | 1,076 | 1,085 | -35 | -3.1% | 234,000 |
2012/12/04 | 1,112 | 1,126 | 1,106 | 1,120 | +10 | +0.9% | 107,000 |
2012/12/03 | 1,107 | 1,112 | 1,103 | 1,110 | +6 | +0.5% | 118,000 |
2012/11/30 | 1,116 | 1,116 | 1,101 | 1,104 | -12 | -1.1% | 116,000 |
2012/11/29 | 1,094 | 1,118 | 1,094 | 1,116 | +7 | +0.6% | 113,000 |
2012/11/28 | 1,124 | 1,126 | 1,108 | 1,109 | -17 | -1.5% | 103,000 |
2012/11/27 | 1,125 | 1,138 | 1,123 | 1,126 | +1 | +0.1% | 108,000 |
3001~
3050
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
持田薬 | 297,600円 | +5.1% | -7.0% | 2.69% | 19.54倍 | 0.81倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ジーエヌアイ | 297,100円 | +21.7% | +999.9% | 0.00% | 12.45倍 | 4.12倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
ゼリア新薬 | 213,700円 | +3.1% | -6.5% | 2.25% | 9.92倍 | 1.05倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
杏林製薬 | 146,000円 | -2.4% | -52.3% | 3.90% | 17.47倍 | 0.62倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 200,000円 | +4.1% | -3.1% | 2.90% | 17.54倍 | 1.53倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム